Penn immunotherapy spin-out raises $100M

Tmunity Therapeutics Inc., a Philadelphia-based developer of immunotherapy treatments that was spun out of the University of Pennsylvania, raised $100 million in a private stock sale. The company was co-founded in 2015 by Penn T cell therapy pioneer Dr. Carl June. The company is developing a diversified portfolio of novel treatments that involve re-engineering a person's own T cells, a key part of the immune system, to boost his or her ability to fight disease. June led Penn’ s development of…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news